FDA approves GlaxoSmithKline renal cancer drug - MarketWatch PDF Print
MarketWatch... and Drug Administration has approved the use of its Votrient medication to treat patients with advanced renal cell carcinoma, a form of kidney cancer.

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.